-- Hikma Agrees to Buy Baxter Injectibles Business for $112 Million in Cash
-- B y   A n g e l a   C u l l e n
-- 2010-10-29T06:02:42Z
-- http://www.bloomberg.com/news/2010-10-29/hikma-agrees-to-buy-baxter-injectibles-business-for-112-million-in-cash.html
Hikma Pharmaceuticals Plc agreed to
buy Baxter Healthcare Corp.â€™s U.S. generic injectibles business
for $112 million in cash.  To contact the editor responsible for this story:
Angela Cullen at 
 acullen8@bloomberg.net  